As a meta-analysis, the present study allows us to get a better understanding on the prognostic role of YKL-40 expression in breast cancer patients by increasing the statistical power through combining data from numerous studies, however, several limitations in the meta-analysis should not be neglected as well. This evidence concerns the gene CHI3L1 and breast carcinoma.